In This Article:
As the U.S. stock market experiences fluctuations with mixed futures following a strong rally, investors are keenly observing corporate earnings and economic indicators that could influence future trends. In this environment, identifying stocks that may be undervalued provides an opportunity for investors to consider potential discounts, especially when these equities show promise despite broader market volatility.
Top 10 Undervalued Stocks Based On Cash Flows In The United States
Name | Current Price | Fair Value (Est) | Discount (Est) |
Flushing Financial (NasdaqGS:FFIC) | $14.51 | $28.35 | 48.8% |
Atlantic Union Bankshares (NYSE:AUB) | $37.87 | $75.40 | 49.8% |
Heartland Financial USA (NasdaqGS:HTLF) | $66.23 | $129.87 | 49% |
Afya (NasdaqGS:AFYA) | $15.74 | $30.63 | 48.6% |
CI&T (NYSE:CINT) | $6.47 | $12.57 | 48.5% |
Privia Health Group (NasdaqGS:PRVA) | $22.68 | $44.59 | 49.1% |
Sociedad Química y Minera de Chile (NYSE:SQM) | $38.48 | $75.05 | 48.7% |
BeiGene (NasdaqGS:ONC) | $222.22 | $437.98 | 49.3% |
Equifax (NYSE:EFX) | $271.88 | $535.10 | 49.2% |
Coeur Mining (NYSE:CDE) | $6.36 | $12.67 | 49.8% |
Underneath we present a selection of stocks filtered out by our screen.
HealthEquity
Overview: HealthEquity, Inc. offers technology-enabled services platforms for consumers and employers in the United States, with a market cap of approximately $9.08 billion.
Operations: HealthEquity's revenue segment includes Pharmacy Services, generating $1.15 billion.
Estimated Discount To Fair Value: 44.1%
HealthEquity is trading at US$105.77, significantly below its estimated fair value of US$189.22, indicating potential undervaluation based on cash flows. Despite recent insider selling and a settlement expense impacting earnings, the company has shown strong revenue growth, with earnings rising by 231.9% over the past year. Forecasts suggest annual profit growth of 41%, outpacing the broader US market, while revenue is expected to grow at 10% annually.
AngloGold Ashanti
Overview: AngloGold Ashanti plc is a gold mining company with operations in Africa, Australia, and the Americas, and it has a market cap of approximately $14.08 billion.
Operations: The company's revenue segment is primarily derived from Metals & Mining - Gold & Other Precious Metals, amounting to $5.30 billion.
Estimated Discount To Fair Value: 45.9%
AngloGold Ashanti, trading at US$27.95, is significantly undervalued against its estimated fair value of US$51.70, reflecting potential based on cash flows. Despite recent insider selling and large one-off items affecting results, the company turned profitable this year with net income reaching US$534 million for the first nine months of 2024. Earnings are forecast to grow substantially by 52.7% annually over the next three years, surpassing market growth expectations.